Clinical Trial

Metabolic Syndrome-Associated Periodontal Inflammatory Surface Area

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 21, 2026 (before its estimated May 25, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to examine the potential of metabolic syndrome (MetS), a systemic, inflammatory disease, to influence the relationship between periodontal inflammatory surface area (PISA) and diabetes and obesity parameters. The primary question addressed by the study is: Can PISA be used as a significant parameter in the relationship between periodontal disease and MetS? In this context, the relationship between PISA and periodontal clinical parameters and serum parameters directly related to the diagnosis of MetS will be examined.
Trial Details
NCT Number NCT07354815
Lead Sponsor Recep Tayyip Erdogan University Training and Research Hospital
Conditions Metabolic Syndrome (MetS), Periodontitis
Enrollment 100 participants
Start Date 2026-02-23
Primary Completion 2026-05-25 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-21